Chemours (CC) Change in Accured Expenses (2014 - 2026)

Chemours' Change in Accured Expenses history runs 13 years deep, the most recent figure standing at $12.0 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 340.0% year-over-year to $12.0 million; the TTM figure through Mar 2026 stood at $14.0 million (up 102.26% YoY), while the FY2025 annual figure was -$3.0 million, up 99.55% from the prior year.
• Change in Accured Expenses was $12.0 million for Q1 2026 at Chemours, up from -$95.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $602.0 million in Q2 2023 to a low of -$644.0 million in Q2 2024.
• Historically, Change in Accured Expenses has averaged -$3.3 million across 5 years, with a median of -$5.0 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses tumbled 206.98% in 2024, then surged 340.0% in 2026.
• A 5-year view of Change in Accured Expenses shows it stood at -$319.0 million in 2022, then soared by 94.36% to -$18.0 million in 2023, then slumped by 100.0% to -$36.0 million in 2024, then sank by 163.89% to -$95.0 million in 2025, then surged by 112.63% to $12.0 million in 2026.
• The last three Change in Accured Expenses figures came in at $12.0 million (Q1 2026), -$95.0 million (Q4 2025), and $22.0 million (Q3 2025), per Business Quant data.